Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) EBIT Margin: 2021

Historic EBIT Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Dec 2021 value amounting to 63.06%.

  • Atea Pharmaceuticals' EBIT Margin was N/A to 63.06% in Q4 2021 from the same period last year, while for Dec 2021 it was 39.38%, marking a year-over-year change of. This contributed to the annual value of 39.38% for FY2021, which is 6206.00% up from last year.
  • Atea Pharmaceuticals' EBIT Margin amounted to 63.06% in Q4 2021, which was up 193.42% from -67.50% recorded in Q3 2021.
  • Atea Pharmaceuticals' 5-year EBIT Margin high stood at 63.06% for Q4 2021, and its period low was -67.50% during Q3 2021.
  • Its 1-year average for EBIT Margin is 14.10%, with a median of 30.42% in 2021.